Brown and Beige Adipose Tissue: One or Different Targets for Treatment of Obesity and Obesity-Related Metabolic Disorders?

被引:1
作者
Kononova, Yulia A. [1 ]
Tuchina, Taisiia P. [2 ]
Babenko, Alina Yu. [1 ]
机构
[1] Almazov Natl Med Res Ctr, Ctr Personalized Med, World Class Sci Ctr, St Petersburg 197341, Russia
[2] Almazov Natl Med Res Ctr, Endocrinol Dept, St Petersburg 197341, Russia
基金
俄罗斯科学基金会;
关键词
brown adipose tissue; beige adipose tissue; obesity; metabolic health; genetic pathways of browning; thermogenesis-affecting drugs; INSULIN SENSITIVITY; THYROID-HORMONES; ACID-METABOLISM; GLUCOSE-UPTAKE; PPAR-ALPHA; WHITE; THERMOGENESIS; METFORMIN; FAT; RESVERATROL;
D O I
10.3390/ijms252413295
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The failure of the fight against obesity makes us turn to new goals in its treatment. Now, brown adipose tissue has attracted attention as a promising target for the treatment of obesity and associated metabolic disorders such as insulin resistance, dyslipidemia, and glucose tolerance disorders. Meanwhile, the expansion of our knowledge has led to awareness about two rather different subtypes: classic brown and beige (inducible brown) adipose tissue. These subtypes have different origin, differences in the expression of individual genes but also a lot in common. Both tissues are thermogenic, which means that, by increasing energy consumption, they can improve their balance with excess intake. Both tissues are activated in response to specific inducers (cold, beta-adrenergic receptor activation, certain food and drugs), but beige adipose tissue transdifferentiates back into white adipose tissue after the cessation of inducing action, while classic brown adipose tissue persists, but its activity decreases. In this review, we attempted to understand whether there are differences in the effects of different groups of thermogenesis-affecting drugs on these tissues. The analysis showed that this area of research is rather sparse and requires close attention in further studies.
引用
收藏
页数:26
相关论文
共 127 条
  • [1] Harb E., Kheder O., Poopalasingam G., Rashid R., Srinivasan A., Izzi-Engbeaya C., Brown adipose tissue and regulation of human body weight, Diabetes Metab. Res. Rev, 39, (2023)
  • [2] Pilkington A.C., Paz H.A., Wankhade U.D., Beige Adipose Tissue Identification, Front. Endocrinol, 12, (2021)
  • [3] Ghesmati Z., Rashid M., Fayezi S., Gieseler F., Alizadeh E., Darabi M., An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications, Rev. Endocr. Metab. Disord, 25, pp. 279-308, (2024)
  • [4] Ziqubu K., Dludla P., Mabhida S., Jack B.U., Keipert S., Jastroch M., Mazibuko-Mbeje S.E., Brown adipose tissue-derived metabolites and their role in regulating metabolism, Metabolism, 150, (2024)
  • [5] Fernandes-da-Silva A., Rangel-Azevedo C., Santana-Olivera D.A., Endoplasmic reticulum stress as the basis of obesity and metabolic diseases: Focus on adipose tissue, liver, and pancreas, J. Nutr. Biochem, 105, (2022)
  • [6] Scheele C., Wolfrum C., Brown Adipose Crosstalk in Tissue Plasticity and Human Metabolism, Endocr. Rev, 41, pp. 53-65, (2020)
  • [7] McNeill B.T., Suchacki K.J., Stimson R.H., Mechanism in endocrinology: Human brown adipose tissue as a therapeutic target: Warming up or cooling down?, Eur. J. Endocrinol, 184, pp. R243-R259, (2021)
  • [8] Markina N.O., Matveev G.A., Zasypkin G.G., Golikova T.I., Ryzhkova D.V., Kononova Y.A., Danilov S.D., Babenko A.Y., Role of Brown Adipose Tissue in MetabolicHealth and Efficacy of Drug Treatment for Obesity, J. Clin. Med, 13, (2024)
  • [9] Ikeda K., Kang Q., Yoneshiro T., Camporez J.P., Maki H., Homma M., Shinoda K., Chen Y., Lu X., Maretich P., Et al., UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis, Nat. Med, 23, pp. 1454-1465, (2017)
  • [10] Chen Y.C., Cypess A.M., Palmer M., Kolodny G., Kahn C.R., Kwong K.K., Measurement of human brown adipose tissue volume and activity using anatomic MR imaging and functional MR imaging, J. Nucl. Med, 54, pp. 1584-1587, (2013)